Professor | Shufen Li | Asia Growth Partners

	Upload Avatar (500 x 500)
Name	Shufen Li
Contact Information	lishufen@wh.iov.cn
Language ability	Chinese, English
Province	Hubei

Upload Avatar (500 x 500)

Name

Shufen Li

Contact Information

lishufen@wh.iov.cn

Language ability

Chinese, English

Province

Hubei

University/Lab Affiliation and Title	University of Chinese Academy of Sciences
Faculty	Life Sciences
Academic Background & Achievements	2009-09 to 2015-06 PhD: Wuhan Institute of Virology, Chinese Academy of Sciences 2005-09 to 2009-06 Bachelor: Nanchang University
Work Experience	2021-10 to Present - Wuhan Institute of Virology, Chinese Academy of Sciences - Associate Researcher 2017-07 to 2021-10 - Wuhan Institute of Virology, Chinese Academy of Sciences - Assistant Researcher 2015-07 to 2017-06 - Guangdong Entry-Exit Inspection and Quarantine Bureau - Postdoctoral Researcher

University/Lab Affiliation and Title

University of Chinese Academy of Sciences

Faculty

Life Sciences

Academic Background & Achievements

2009-09 to 2015-06 PhD: Wuhan Institute of Virology, Chinese Academy of Sciences
2005-09 to 2009-06 Bachelor: Nanchang University

Work Experience

2021-10 to Present - Wuhan Institute of Virology, Chinese Academy of Sciences - Associate Researcher
2017-07 to 2021-10 - Wuhan Institute of Virology, Chinese Academy of Sciences - Assistant Researcher
2015-07 to 2017-06 - Guangdong Entry-Exit Inspection and Quarantine Bureau - Postdoctoral Researcher

Areas of Focus	Virus-host interactions Inflammatory responses Anti-inflammatory drugs
Publications	SARS-CoV-2 Z-RNA activates the ZBP1-RIPK3 pathway to promote virus-induced inflammatory responses, First Author, 2023 Bioactive compounds from Huashi Baidu decoction possess both antiviral and anti-inflammatory effects against COVID-19, Second Author, 2023 ACE2-independent infection of T lymphocytes by SARS-CoV-2, Fifth Author, 2022 Antibody-dependent cellular cytotoxicity response to SARS-CoV-2 in COVID-19 patients, Fourth Author, 2021 High-Throughput Screening of an FDA-Approved Drug Library Identifies Inhibitors against Arenaviruses and SARS-CoV-2, Third Author, 2021 Screening of a Small Molecule Compound Library Identifies Toosendanin as an Inhibitor Against Bunyavirus and SARS-CoV-2, First Author, 2021 Viral dynamics and antibody responses in people with asymptomatic SARS-CoV-2 infection, Sixth Author, 2021 SARS-CoV-2 triggers inflammatory responses and cell death through caspase-8 activation, First Author, 2020 Calcium channel blocker amlodipine besylate therapy is associated with reduced case fatality rate of COVID-19 patients with hypertension, Eighth Author, 2020 SFTSV Infection Induces BAK/BAX-Dependent Mitochondrial DNA Release to Trigger NLRP3 Inflammasome Activation, First Author, 2020 Host factor heat-shock protein 90 contributes to baculovirus budded virus morphogenesis via facilitating nuclear actin polymerization, First Author, 2019 Calcium channel blockers reduce severe fever with thrombocytopenia syndrome virus (SFTSV) related fatality, Third Author, 2019 NSs Filament Formation Is Important but Not Sufficient for RVFV Virulence In Vivo, First Author, 2019 Patient-derived avian influenza A (H5N6) virus is highly pathogenic in mice but can be effectively treated by anti-influenza polyclonal antibodies, Zero Author, 2018 Morphologic and Molecular Characterization of a Strain of Zika Virus Imported into Guangdong, China, First Author, 2017 Isolation and phylogenetic study of Rift Valley fever virus from the first imported case to China, Fifth Author, 2017 Mutational and functional analysis of N-linked glycosylation of envelope fusion protein F of Helicoverpa armigera nucleopolyhedrovirus, Fourth Author, 2016 The FP25K Acts as a Negative Factor for the Infectivity of AcMNPV Budded Virus, First Author, 2015 搭建流行病探测网络, Third Author, 2014 Genetic Modification of Baculovirus Expression Vectors, First Author, 2012

Areas of Focus

Virus-host interactions
Inflammatory responses
Anti-inflammatory drugs

Publications

SARS-CoV-2 Z-RNA activates the ZBP1-RIPK3 pathway to promote virus-induced inflammatory responses, First Author, 2023
Bioactive compounds from Huashi Baidu decoction possess both antiviral and anti-inflammatory effects against COVID-19, Second Author, 2023
ACE2-independent infection of T lymphocytes by SARS-CoV-2, Fifth Author, 2022
Antibody-dependent cellular cytotoxicity response to SARS-CoV-2 in COVID-19 patients, Fourth Author, 2021
High-Throughput Screening of an FDA-Approved Drug Library Identifies Inhibitors against Arenaviruses and SARS-CoV-2, Third Author, 2021
Screening of a Small Molecule Compound Library Identifies Toosendanin as an Inhibitor Against Bunyavirus and SARS-CoV-2, First Author, 2021
Viral dynamics and antibody responses in people with asymptomatic SARS-CoV-2 infection, Sixth Author, 2021
SARS-CoV-2 triggers inflammatory responses and cell death through caspase-8 activation, First Author, 2020
Calcium channel blocker amlodipine besylate therapy is associated with reduced case fatality rate of COVID-19 patients with hypertension, Eighth Author, 2020
SFTSV Infection Induces BAK/BAX-Dependent Mitochondrial DNA Release to Trigger NLRP3 Inflammasome Activation, First Author, 2020
Host factor heat-shock protein 90 contributes to baculovirus budded virus morphogenesis via facilitating nuclear actin polymerization, First Author, 2019
Calcium channel blockers reduce severe fever with thrombocytopenia syndrome virus (SFTSV) related fatality, Third Author, 2019
NSs Filament Formation Is Important but Not Sufficient for RVFV Virulence In Vivo, First Author, 2019
Patient-derived avian influenza A (H5N6) virus is highly pathogenic in mice but can be effectively treated by anti-influenza polyclonal antibodies, Zero Author, 2018
Morphologic and Molecular Characterization of a Strain of Zika Virus Imported into Guangdong, China, First Author, 2017
Isolation and phylogenetic study of Rift Valley fever virus from the first imported case to China, Fifth Author, 2017
Mutational and functional analysis of N-linked glycosylation of envelope fusion protein F of Helicoverpa armigera nucleopolyhedrovirus, Fourth Author, 2016
The FP25K Acts as a Negative Factor for the Infectivity of AcMNPV Budded Virus, First Author, 2015
搭建流行病探测网络, Third Author, 2014
Genetic Modification of Baculovirus Expression Vectors, First Author, 2012

Virus Host Interaction Inflammation Response Anti-Inflammatory Drug Sars-Cov-2 Covid-19 Research

Ping Zhang - University of Chinese Academy of Sciences

Yudong Cai - Shanghai University

Yudong Cai - Shanghai University

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us